Swiss non-profit drugmakers team up as funding shrinks

Waning commitments to global health causes and big pharma’s financial imperatives are threatening the development of innovative drugs to help patients left on the sidelines of medicine. A malaria therapy for newborns, an antiviral medicine against chronic hepatitis C, and an antibiotic to treat gonorrhea are among new drugs developed by three Geneva-based non-profit organisations that will be launched in various low- and middle-income countries in the coming months. And these are just the…